株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国のチモペンチン市場の分析

Investigation Report on Chinese Thymopentin Market, 2018-2022

発行 China Research and Intelligence 商品コード 660258
出版日 ページ情報 英文 30 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.52円で換算しております。
Back to Top
中国のチモペンチン市場の分析 Investigation Report on Chinese Thymopentin Market, 2018-2022
出版日: 2018年07月05日 ページ情報: 英文 30 Pages
概要

当レポートでは、中国におけるチモペンチンの市場について分析し、全体的な市場規模の動向(過去5年間分)や国内価格の動向、市場競争パターン (企業別市場シェアなど)、主要メーカーのプロファイル、将来的な市場動向の見通し(今後5年間分)などを調査しております。

第1章 チモペンチンの関連概念

  • 適応症
  • 中国国内でのチモペンチンの開発の歴史

第2章 中国のチモペンチン市場の概要

  • チモペンチンに対する政府認証
  • 主要メーカー

第3章 中国国内のチモペンチン販売動向 (過去5年間分)

  • 売上高 (金額ベース)
    • 全体的な総売上高
    • 地域別の売上高
  • 販売量 (数量ベース)
    • 全体的な総販売量
    • 地域別の販売量

第4章 中国のチモペンチン主要メーカーの市場シェア (過去5年間分)

  • 市場シェア (金額ベース)
  • 市場シェア (数量ベース)

第5章 チモペンチン市場の動向:剤型別 (過去5年間分)

  • 市場シェア:剤型別 (金額ベース)
  • 市場シェア:剤型別 (数量ベース)

第6章 中国市場でのチモペンチンの参考価格 (販売価格):企業別

  • Hainan Zhonghe Pharmaceutical Co., Ltd. (商標名:Hexin)
  • Beijing SL Pharmaceutical Co., Ltd. (商標名:Ouning)
  • Beijing Sciecure Pharmaceutical Co., Ltd. (商標名:Tongda)
  • Wuhan Hualong Bio-pharmaceutical Co., Ltd. (商標名:Ruilineng)
  • Hybio Pharmaceutical Co., Ltd. (商標名:Hanning)
  • Sinopharm A-Think Pharmaceutical Co., Ltd. (商標名:Liertai)
  • Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd. (商標名:Guole)
  • Yangtze River Pharmaceutical (Group) Co., Ltd. (商標名:Suwei)
  • Chengdu DIAO Jiuhong Pharmaceutical Factory (商標名:Tiboding)
  • Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.

第7章 中国国内のチモペンチン主要メーカー

  • Hainan Zhonghe Pharmaceutical Co., Ltd.
  • Beijing SL Pharmaceutical Co., Ltd.
  • Beijing Sciecure Pharmaceutical Co., Ltd.
  • Wuhan Hualong Bio-pharmaceutical Co., Ltd.
  • Hybio Pharmaceutical Co., Ltd.
  • Sinopharm A-Think Pharmaceutical Co., Ltd.
  • Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd.
  • Yangtze River Pharmaceutical (Group) Co., Ltd.
  • Chengdu DIAO Jiuhong Pharmaceutical Factory
  • Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.

第8章 中国のチモペンチン市場の将来展望 (今後5年間分)

  • 市場規模の予測
  • 競争パターンの予測
目次
Product Code: 1806298

Thymopentin is a two-way immune-regulator, i.e. it can handle both immune hypofunction and hyperfunction. The indications include chronic hepatitis B and primary or secondary T-cell deficiencies. Thymopentin can also help treat some autoimmune diseases and tumors.

As an important active component of human thymus hormone, Thymopentin is artificially synthesized and free of allergenic protein and reaction, which significantly enhances the effect of Thymopentin as a substitute for thymosin injections. Therefore, Thymopentin is a strong performer among thymosin drugs.

In 1985, Thymopentin for Injection was launched in Italy in the trade name of "Timunox". In 1997, Hainan Zhonghe Pharmaceutical Co., Ltd. First launched Thymopentin for Injection (trade name: Hexin), China's first two-way immunomodulator of synthetic polypeptide after independent research and development. The product once played an important role in the fight against SARS in 2003. Later, other enterprises including Beijing SL Pharmaceutical Co., Ltd. Were approved to produce Thymopentin. Because of a low technological barrier, there are many manufacturers and fierce competitions in the market. Thymopentin is only sold in China as a Chinese-style drug.

According to CRI, in 2017, the sales value of Thymopentin exceeded CNY 1 billion in the Chinese market dominated by Hainan Zhonghe Pharmaceutical Co., Ltd., Beijing SL Pharmaceutical Co., Ltd., Beijing Sciecure Pharmaceutical Co., Ltd. And Hybio Pharmaceutical Co., Ltd. The sales value of top 10 enterprises took up about 99% of the market. The sales value of Hainan Zhonghe ranked first with a market share over 30%.

It is expected that the Chinese Thymopentin still has large potentials to grow in the coming years.

Topics Covered::

  • Development of Chinese Thymopentin Market
  • Size of Chinese Thymopentin Market
  • Competition Pattern of Chinese Thymopentin Market
  • Thymopentin Prices in Chinese Thymopentin Market
  • Prospects of Chinese Thymopentin Market

Table of Contents

1 Relevant Concepts of Thymopentin

  • 1.1 Indications
  • 1.2 Development History of Thymopentin in China

2 Market Overview of Thymopentin in China

  • 2.1 Governmental Approval of Thymopentin in China
  • 2.2 Major Manufacturers

3 Sales of Thymopentin in China, 2013-2017

  • 3.1 Sales Value of Thymopentin
    • 3.1.1 Overall Sales Value
    • 3.1.2 Sales Value in Different Regions
  • 3.2 Sales Volume
    • 3.2.1 Overall Sales Volume
    • 3.2.2 Sales Volume in Different Regions

4 Investigation on Market Share of Major Thymopentin Manufacturers in China, 2013-2017

  • 4.1 Market Share by Sales Value
  • 4.2 Market Share by Sales Volume

5 Thymopentin in Different Dosage Forms, 2013-2017

  • 5.1 Market Share of Dosage Forms by Sales Value
  • 5.2 Market Share of Dosage Forms by Sales Volume

6 Reference Sale Price of Major Thymopentin Products in Chinese Market, 2017-2018

  • 6.1 Hainan Zhonghe Pharmaceutical Co., Ltd. (Trade Name: Hexin)
  • 6.2 Beijing SL Pharmaceutical Co., Ltd. (Trade Name: Ouning)
  • 6.3 Beijing Sciecure Pharmaceutical Co., Ltd. (Trade Name: Tongda)
  • 6.4 Wuhan Hualong Bio-pharmaceutical Co., Ltd. (Trade Name: Ruilineng)
  • 6.5 Hybio Pharmaceutical Co., Ltd. (Trade Name: Hanning)
  • 6.6 Sinopharm A-Think Pharmaceutical Co., Ltd. (Trade Name: Liertai)
  • 6.7 Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd. (Trade Name: Guole)
  • 6.8 Yangtze River Pharmaceutical (Group) Co., Ltd. (Trade Name: Suwei)
  • 6.9 Chengdu DIAO Jiuhong Pharmaceutical Factory (Trade Name: Tiboding)
  • 6.10 Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.

7 Major Thymopentin Manufacturers in China, 2013-2017

  • 7.1 Hainan Zhonghe Pharmaceutical Co., Ltd.
  • 7.2 Beijing SL Pharmaceutical Co., Ltd.
  • 7.3 Beijing Sciecure Pharmaceutical Co., Ltd.
  • 7.4 Wuhan Hualong Bio-pharmaceutical Co., Ltd.
  • 7.5 Hybio Pharmaceutical Co., Ltd.
  • 7.6 Sinopharm A-Think Pharmaceutical Co., Ltd.
  • 7.7 Shanghai Huayuan Pharmacy (Ningxia) Shasai Pharmaceutical Co., Ltd.
  • 7.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
  • 7.9 Chengdu DIAO Jiuhong Pharmaceutical Factory
  • 7.10 Henan Furen Huaiqingtang Pharmaceutical Co., Ltd.

8 Prospects of Chinese Thymopentin Market, 2018-2022

  • 8.1 Forecast on Market Size
  • 8.2 Forecast on Competition Pattern

Selected Charts

  • Chart Governmental Approval of Thymopentin in China
  • Chart Sales of Thymopentin in China, 2013-2017
  • Chart Sales Value of Thymopentin in China, 2013- 2017
  • Chart Sales Value of Thymopentin in Regions of China, 2013-2017
  • Chart Sales Volume of Thymopentin in China, 2013- 2017
  • Chart Market Share and Sales Value of Hainan Zhonghe's Thymopentin in China, 2013-2017
  • Chart Market Share and Sales Value of Beijing SL's Thymopentin in China, 2013-2017
  • Chart Market Share and Sales Value of Beijing Sciecure's Thymopentin in China, 2013-2017
  • Chart Market Share and Sales Value of Hybio's Thymopentin in China, 2013-2017
  • Chart Market Share and Sales Value of Wuhan Hualong's Thymopentin in China, 2013-2017
  • Chart Prices of Wuhan Hualong's Thymopentin in Several Chinese Cities, 2017-2018
  • Chart Prices of Beijing Sciecure's Thymopentin in Several Chinese Cities, 2017-2018
  • Chart Prices of Beijing SL's Thymopentin in Several Chinese Cities, 2017-2018
  • Chart Forecast on Thymopentin's Sales in China, 2018-2022
Back to Top